Vistagen Therapeutics, Inc. (VTGN)
0.1706
0.00 (0.00%)
USD |
NASDAQ |
Oct 29, 16:00
0.1706
0.00 (0.00%)
After-Hours: 18:53
Vistagen Therapeutics Price to Book Value : 0.3093 for Oct. 29, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 28, 2026 | 0.3082 |
| October 27, 2026 | 0.3154 |
| October 26, 2026 | 0.3151 |
| October 23, 2026 | 0.3258 |
| October 22, 2026 | 0.339 |
| October 21, 2026 | 0.351 |
| October 20, 2026 | 0.3586 |
| October 19, 2026 | 0.3682 |
| October 16, 2026 | 0.3626 |
| October 15, 2026 | 0.3861 |
| October 14, 2026 | 0.3745 |
| October 13, 2026 | 0.3894 |
| October 12, 2026 | 0.4108 |
| October 09, 2026 | 0.428 |
| October 08, 2026 | 0.4463 |
| October 07, 2026 | 0.448 |
| October 06, 2026 | 0.4543 |
| October 05, 2026 | 0.4772 |
| October 02, 2026 | 0.5094 |
| October 01, 2026 | 0.5123 |
| September 30, 2026 | 0.558 |
| September 29, 2026 | 0.5402 |
| September 28, 2026 | 0.5384 |
| September 25, 2026 | 0.4949 |
| September 24, 2026 | 0.5348 |
| Date | Value |
|---|---|
| September 23, 2026 | 0.6679 |
| September 22, 2026 | 0.4558 |
| September 21, 2026 | 0.4224 |
| September 18, 2026 | 0.4351 |
| September 17, 2026 | 0.4235 |
| September 16, 2026 | 0.4181 |
| September 15, 2026 | 0.428 |
| September 14, 2026 | 0.4409 |
| September 11, 2026 | 0.4297 |
| September 10, 2026 | 0.4333 |
| September 09, 2026 | 0.4269 |
| September 08, 2026 | 0.4413 |
| September 04, 2026 | 0.4402 |
| September 03, 2026 | 0.4463 |
| September 02, 2026 | 0.446 |
| September 01, 2026 | 0.4411 |
| August 31, 2026 | 0.4623 |
| August 28, 2026 | 0.4585 |
| August 27, 2026 | 0.4659 |
| August 26, 2026 | 0.4714 |
| August 25, 2026 | 0.4503 |
| August 24, 2026 | 0.442 |
| August 21, 2026 | 0.4423 |
| August 20, 2026 | 0.4371 |
| August 19, 2026 | 0.4425 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Onconetix, Inc. | 0.1630 |
| ACADIA Pharmaceuticals, Inc. | 2.734 |
| Alnylam Pharmaceuticals, Inc. | 17.17 |
| Anika Therapeutics, Inc. | 2.122 |
| Savara, Inc. | 7.084 |
Price to Book Value Related Metrics
| PS Ratio | 2.737 |
| Price | 0.1706 |
| Earnings Yield | -999.2% |
| Market Cap | 7.571M |